1. Home
  2. HOFT vs MNOV Comparison

HOFT vs MNOV Comparison

Compare HOFT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

N/A

Current Price

$13.02

Market Cap

143.7M

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$2.07

Market Cap

137.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOFT
MNOV
Founded
1924
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.7M
137.8M
IPO Year
1999
2004

Fundamental Metrics

Financial Performance
Metric
HOFT
MNOV
Price
$13.02
$2.07
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
42.2K
★ 729.7K
Earning Date
04-16-2026
05-14-2026
Dividend Yield
★ 3.79%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.25
N/A
Revenue
N/A
★ $2,360,807.00
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
$180.00
P/E Ratio
$52.56
★ N/A
Revenue Growth
N/A
★ 194.15
52 Week Low
$8.62
$1.17
52 Week High
$18.09
$3.90

Technical Indicators

Market Signals
Indicator
HOFT
MNOV
Relative Strength Index (RSI) 41.99 43.17
Support Level $12.03 $1.28
Resistance Level $13.71 $3.90
Average True Range (ATR) 0.65 0.35
MACD 0.04 -0.04
Stochastic Oscillator 37.52 4.98

Price Performance

Historical Comparison
HOFT
MNOV

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: